NORML

FEBRUARY 23, 2020

This bill comes after lawmakers passed legislation in 2019 that allows the growing and production of hemp and hemp-derived products, as long as the THC concentration is below 0.3%. The bill would allow qualifying patients to access all the alternative treatment centers instead of having to designate just one. NH resident? OK resident?

Legislation 253

Legislation Patients Decriminalization Access 253

Canna Care Docs

JUNE 18, 2018

CBD is one of close to 85 cannabinoids present in cannabis, with THC being the most commonly known. Cannabidiol as a Potential Treatment for Anxiety Disorders. 9-tetrahydrocannabinol (THC) by vaporisation. doi:10.1186/2050-6511-15-58. Neurotherapeutics. 2015;12(4):825-836. doi:10.1007/s13311-015-0387-1. 2014;15(1).

Clinical Trials 75

Clinical Trials CBD Epilepsy Patients 75

Alchimia

MARCH 16, 2016

Patient associations estimate that we’ll have around 1,5 million people suffering from Alzheimer in Spain by 2050. Although a balanced nutrition – and regular brain stimulation – can have protective and preventive effects , we still don’t have any effective treatment for Alzheimer’s disease once it is active.

Cannabinoids 76

Cannabinoids Research and Development Treatment Patients 76

Cannabis Law Report

JUNE 21, 2021

We conclude that in medical-only access models there is little evidence to justify the differential treatment of medicinal cannabis patients, compared with those taking other prescription medications with potentially impairing effects. Access to treatment. Daniel Perkins a b Hugh Brophy a Iain S. Medicinal cannabis. Road safety.

Medicine 45

Medicine Safety Policy Treatment 45

MMJ Recs

MAY 25, 2022

Pain management centers can be a good addition to treatment for medical marijuana patients who experience chronic pain. These Virginia pain specialists utilize various treatments to reduce chronic pain and improve the lives of their patients. Medical Marijuana Treatment For Chronic Pain. What Is Chronic Pain?

Chronic Pain 52

Chronic Pain Patients Treatment Therapy 52

Cannabis Law Report

JUNE 12, 2021

A notable example of this is the so-called ‘zero tolerance’ drug driving legal frameworks, which criminalise the presence of THC (tetrahydrocannabinol) in a driver’s bodily fluids irrespective of impairment. The Lambert Initiative for Cannabinoid Therapeutics, Brain and Mind Centre, The University of Sydney, Sydney, NSW 2050, Australia.

Policy 51

Policy Safety Medicine Access 51

Cannabis Cheri

AUGUST 1, 2019

A major concern is that the number of people with Alzheimer’s disease is expected to escalate substantially as baby boomers enter their “golden years” with an estimated 16 million people developing Alzheimer’s by 2050. The study noted that THC is a “superior inhibitor” of this plaque compared to drugs currently used to treat Alzheimer’s.

Research and Development 267

Research and Development Cannabis Patients Cannabinoids 267